Previous 10 | Next 10 |
NEWTOWN, Pa., June 07, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the JMP Securities Lif...
NEWTOWN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that three new clinics have been authorized to provide PoNS...
Glancy Prongay & Murray LLP (“GPM”) announces the continuation of its investigation on behalf of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors concerning the Company and its officers’ possible vio...
Helius Medical Technologies, Inc. (HSDT) Q1 2019 Earnings Conference Call May 9, 2019 16:30 ET Company Participants Phil Deschamps - CEO Joyce LaViscount - CFO & COO Conference Call Participants Marie Thibault - BTIG Presentation Operator Good afternoon, ladies ...
Helius Medical Technologies (NASDAQ: HSDT ): Q1 GAAP EPS of -$0.06 beats by $0.20 . More news on: Helius Medical Technologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEWTOWN, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the first quarter ended March 31, 2019...
Establishment Labs Could Become The Next Hot Medtech Growth Stock Establishment Labs ( ESTA ) manufactures and sells medical devices for aesthetic and reconstructive plastic surgery. It primarily offers silicone gel-filled smooth category breast implants under the Motiva Implants brand nam...
April 18, 2019 Palm Beach, FL –April 18, 2019 – The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency Market Research)...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors concerning the Company and its officers’ possible violations of federal se...
We Found No Fundamental Justification For CFMS 400% Rally We at White Diamond Research are medical device experts. Recently, we have been exposing medical device companies that have inferior devices. Over the last eight months, we have published on Seeking Alpha bearish reports on the follow...
News, Short Squeeze, Breakout and More Instantly...
Helius Medical Technologies Inc. Company Name:
HSDT Stock Symbol:
NASDAQ Market:
NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the C...